Cargando…
miR-21, Mediator, and Potential Therapeutic Target in the Cardiorenal Syndrome
Oligonucleotide-based therapies are currently gaining attention as a new treatment option for relatively rare as well as common diseases such as cardiovascular disease. With the remarkable progression of new sequencing technologies, a further step towards personalized precision medicine to target a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243366/ https://www.ncbi.nlm.nih.gov/pubmed/32499708 http://dx.doi.org/10.3389/fphar.2020.00726 |